LOS ANGELES, CA – Lilly Singh is back with another game-changer. The YouTube star-turned-entrepreneur has launched HYPHEN8, a media network built to help South Asian content creators thrive.

Among the many high-profile attendees, comedian and YouTube star Lilly Singh and Never Have I Ever actress Poorna Jagannathan stood out, bringing their signature energy and style to the event.

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, bolstering the company’s argument that the siRNA candidate has an edge over ...

Eli Lilly is developing what could be the first oral GLP-1 agonist. Late-stage clinical trial data is coming this year. The stock has a steep valuation despite trading sideways since the summer.

Get a high-probability setup with clear entry and exit points right here. Eli Lilly And Co LLY, on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering ...

This week, Justin Bieber debuted a “H-22” tattoo on his wrist. Justin Bieber shut down marriage trouble rumors with some new ink. On Monday, Hailey Bieber appeared to have unfollowed her ...

The boss of US pharmaceutical giant Eli Lilly has told the BBC there is no looking back from Donald Trump's decision to impose sweeping tariffs on imports from the rest of the world. In an ...

Caroline Roberts writes articles and notifications for CNET. She studies English at Cal Poly, and loves philosophy, Karl the Fog and a strong cup of black coffee. Dr. Valerie Cholet is a Professor ...

It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees. The Tribune, the largest selling English daily in ...

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein ...

Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...